156 related articles for article (PubMed ID: 9790344)
21. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease.
Oberg S; Peters JH; DeMeester TR; Chandrasoma P; Hagen JA; Ireland AP; Ritter MP; Mason RJ; Crookes P; Bremner CG
Ann Surg; 1997 Oct; 226(4):522-30; discussion 530-2. PubMed ID: 9351720
[TBL] [Abstract][Full Text] [Related]
22. Intestinal metaplasia of the gastric cardia.
Morales TG; Sampliner RE; Bhattacharyya A
Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
[TBL] [Abstract][Full Text] [Related]
23. Short-segment Barrett's esophagus and cardia intestinal metaplasia: A comparative analysis.
Chang Y; Liu B; Liu GS; Wang T; Gong J
World J Gastroenterol; 2010 Dec; 16(48):6151-4. PubMed ID: 21182233
[TBL] [Abstract][Full Text] [Related]
24. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and gastroesophageal junction.
Jovanovic I; Tzardi M; Mouzas IA; Micev M; Pesko P; Milosavljevic T; Zois M; Sganzos M; Delides G; Kanavaros P
Histol Histopathol; 2002 Apr; 17(2):445-54. PubMed ID: 11962749
[TBL] [Abstract][Full Text] [Related]
25. Relative risk of dysplasia for patients with intestinal metaplasia in the distal oesophagus and in the gastric cardia.
Sharma P; Weston AP; Morales T; Topalovski M; Mayo MS; Sampliner RE
Gut; 2000 Jan; 46(1):9-13. PubMed ID: 10601047
[TBL] [Abstract][Full Text] [Related]
26. Cardiac Metaplasia: Follow, Treat, or Ignore?
Spechler SJ
Dig Dis Sci; 2018 Aug; 63(8):2052-2058. PubMed ID: 29671160
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus.
DeMeester SR; Wickramasinghe KS; Lord RV; Friedman A; Balaji NS; Chandrasoma PT; Hagen JA; Peters JH; DeMeester TR
Am J Gastroenterol; 2002 Oct; 97(10):2514-23. PubMed ID: 12385432
[TBL] [Abstract][Full Text] [Related]
28. Radiofrequency ablation for Barrett's esophagus and low-grade dysplasia in combination with an antireflux procedure: a new paradigm.
dos Santos RS; Bizekis C; Ebright M; DeSimone M; Daly BD; Fernando HC
J Thorac Cardiovasc Surg; 2010 Mar; 139(3):713-6. PubMed ID: 20074750
[TBL] [Abstract][Full Text] [Related]
29. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
[TBL] [Abstract][Full Text] [Related]
30. Comparison of clinical, endoscopic and functional findings in patients with intestinal metaplasia at the cardia, carditis and short-segment columnar epithelium of the distal esophagus with and without intestinal metaplasia.
Csendes A; Smok G; Flores N; Rojas J; Quiroz J; Henriquez A
Dis Esophagus; 2000; 13(1):61-8. PubMed ID: 11005334
[TBL] [Abstract][Full Text] [Related]
31. Histopathology of columnar-lined esophagus in patients with gastroesophageal reflux disease.
Lenglinger J; Ringhofer C; Eisler M; Sedivy R; Wrba F; Zacherl J; Cosentini EP; Prager G; Haefner M; Riegler M
Wien Klin Wochenschr; 2007; 119(13-14):405-11. PubMed ID: 17671821
[TBL] [Abstract][Full Text] [Related]
32. Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features.
Lord RV; Wickramasinghe K; Johansson JJ; Demeester SR; Brabender J; Demeester TR
Surgery; 2004 Sep; 136(3):633-40. PubMed ID: 15349112
[TBL] [Abstract][Full Text] [Related]
33. Cardia-type metaplasia arising in the remnant esophagus after cardia resection.
Peitz U; Vieth M; Pross M; Leodolter A; Malfertheiner P
Gastrointest Endosc; 2004 Jun; 59(7):810-7. PubMed ID: 15173793
[TBL] [Abstract][Full Text] [Related]
34. Progression of specialized intestinal metaplasia at the cardia to macroscopically evident Barrett's esophagus: an entity of concern in the ProGERD study.
Leodolter A; Nocon M; Vieth M; Lind T; Jaspersen D; Richter K; Willich S; Stolte M; Malfertheiner P; Labenz J
Scand J Gastroenterol; 2012 Dec; 47(12):1429-35. PubMed ID: 23110405
[TBL] [Abstract][Full Text] [Related]
35. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
36. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
Mohammed IA; Streutker CJ; Riddell RH
Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
[TBL] [Abstract][Full Text] [Related]
37. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
38. Distinction between short-segment Barrett's esophageal and cardiac intestinal metaplasia.
Liu GS; Gong J; Cheng P; Zhang J; Chang Y; Qiang L
World J Gastroenterol; 2005 Oct; 11(40):6360-5. PubMed ID: 16419166
[TBL] [Abstract][Full Text] [Related]
39. Reflux control is important in the management of Barrett's Esophagus: results from a retrospective 1,830 patient cohort.
Brown CS; Lapin B; Wang C; Goldstein JL; Linn JG; Denham W; Haggerty SP; Talamonti MS; Howington JA; Carbray J; Ujiki MB
Surg Endosc; 2015 Dec; 29(12):3528-34. PubMed ID: 25676204
[TBL] [Abstract][Full Text] [Related]
40. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
Spechler SJ
Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
